Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,052
datasets available to search
ShareScore release 0.9.0
Dataset results
1,052 results for “Cell growth”
Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherap
ClinicalTrials.gov study NCT00041665. IPD Sharing: Not stated. Countries: 0. Publications: 4.
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT03082300. IPD Sharing: NO. Countries: 1. Publications: 0.
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Rese
ClinicalTrials.gov study NCT06192849. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
ClinicalTrials.gov study NCT04643847. IPD Sharing: NO. Countries: 1. Publications: 0.
VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway
ClinicalTrials.gov study NCT01917370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04285671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT02475720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
ClinicalTrials.gov study NCT06585059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05267288. IPD Sharing: NO. Countries: 1. Publications: 0.
Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients
ClinicalTrials.gov study NCT00287677. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)
ClinicalTrials.gov study NCT03151161. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
ClinicalTrials.gov study NCT02321046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
ClinicalTrials.gov study NCT05967689. IPD Sharing: NO. Countries: 12. Publications: 0.
A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations
ClinicalTrials.gov study NCT01897480. IPD Sharing: YES. Countries: 9. Publications: 0.
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
ClinicalTrials.gov study NCT02342353. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
ClinicalTrials.gov study NCT05801029. IPD Sharing: YES. Countries: 6. Publications: 0.
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Meta
ClinicalTrials.gov study NCT07143045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations
ClinicalTrials.gov study NCT06391944. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth
ClinicalTrials.gov study NCT05364073. IPD Sharing: NO. Countries: 11. Publications: 0.
Point-of-Care Adipose-derived Cells for Hair Growth
ClinicalTrials.gov study NCT02729415. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.